Literature DB >> 2102904

Bacterial lipopolysaccharides: structure, metabolism and mechanisms of action.

M A Freudenberg1, C Galanos.   

Abstract

Endotoxins (lipopolysaccharides, LPS) are biologically active substances present in the outer membrane of gram-negative bacteria. They induce a spectrum of biological effects which may be harmful or beneficiary for the host. Lipid A is the biologically active part of the LPS molecule. This was demonstrated using soluble forms of lipid A and more recently confirmed further by employing synthetic lipid A. LPS administered into experimental animals circulates as LPS/HDL complex and is cleared from the blood mainly into the liver and spleen. In the liver LPS undergoes partial deacylation however without a loss of toxic activity. Its excretion is effected mainly via the bile into the gut. The lethal toxicity and tolerance inducing properties of LPS are mediated by macrophages through tumor necrosis factor alpha (TNF alpha), which is probably the most important endogenous mediator of the lethal effects of LPS. The lethal toxicity of LPS may be completely inhibited by anti-TNF alpha antibodies.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2102904     DOI: 10.3109/08830189009056632

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  24 in total

Review 1.  Cell biology of liver endothelial and Kupffer cells.

Authors:  B Smedsrød; P J De Bleser; F Braet; P Lovisetti; K Vanderkerken; E Wisse; A Geerts
Journal:  Gut       Date:  1994-11       Impact factor: 23.059

2.  Cloning of anti-lPS factor cDNA from Tachypleus tridentatus, expression in Bombyx mori larvae and its biological activity in vitro.

Authors:  Dong-Ning Wang; Jie-Wu Liu; Guan-Zhen Yang; Wei-Jie Zhang; Xiang-Fu Wu
Journal:  Mol Biotechnol       Date:  2002-05       Impact factor: 2.695

Review 3.  The sweet tooth of bacteria: common themes in bacterial glycoconjugates.

Authors:  Hanne L P Tytgat; Sarah Lebeer
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

4.  Protective effects of chelerythrine against lipopolysaccharide-induced endotoxic shock in mice.

Authors:  Xiaofeng Niu; Qingli Mu; Weifeng Li; Huimin Huang; Huan Yao; Huani Li
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

5.  Molecular structures that influence the immunomodulatory properties of the lipid A and inner core region oligosaccharides of bacterial lipopolysaccharides.

Authors:  P J Baker; T Hraba; C E Taylor; P W Stashak; M B Fauntleroy; U Zähringer; K Takayama; T R Sievert; X Hronowski; R J Cotter
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

6.  A novel ML protein from Manduca sexta may function as a key accessory protein for lipopolysaccharide signaling.

Authors:  Jing-qun Ao; Erjun Ling; Xiang-jun Rao; Xiao-Qiang Yu
Journal:  Mol Immunol       Date:  2008-03-17       Impact factor: 4.407

Review 7.  Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.

Authors:  Edwin S Van Amersfoort; Theo J C Van Berkel; Johan Kuiper
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

8.  KV 7/M channels as targets for lipopolysaccharide-induced inflammatory neuronal hyperexcitability.

Authors:  Arik Tzour; Hodaya Leibovich; Omer Barkai; Yoav Biala; Shaya Lev; Yoel Yaari; Alexander M Binshtok
Journal:  J Physiol       Date:  2016-10-02       Impact factor: 5.182

9.  Structural features that influence the ability of lipid A and its analogs to abolish expression of suppressor T cell activity.

Authors:  P J Baker; T Hraba; C E Taylor; K R Myers; K Takayama; N Qureshi; P Stuetz; S Kusumoto; A Hasegawa
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

10.  Using distinct molecular signatures of human monocytes and dendritic cells to predict adjuvant activity and pyrogenicity of TLR agonists.

Authors:  Richard Kenmoe Kamgang; Inês Ramos; Lurdes Rodrigues Duarte; Mascia Ghielmetti; Marina Freudenberg; Clemens Dahinden; Elisabetta Padovan
Journal:  Med Microbiol Immunol       Date:  2008-02-19       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.